These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12577933)

  • 21. Significance of serum immunoglobulin M to hepatitis C virus core in patients with chronic hepatitis C.
    Tran A; Yang G; Dreyfus G; Rouquié P; Durant J; Rampal A; Rampal P; Benzaken S
    Am J Gastroenterol; 1997 Oct; 92(10):1835-8. PubMed ID: 9382047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A hepatitis C virus (HCV) core protein derived peptide inhibits HCV specific lymphocyte proliferation.
    Langhans B; Lechmann M; Ihlenfeldt H; Jung G; Giers G; Schweitzer S; El Bakri M; Sauerbruch T; Spengler U
    Eur J Med Res; 2000 Mar; 5(3):115-20. PubMed ID: 10756165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus core protein: its coordinate roles with PA28gamma in metabolic abnormality and carcinogenicity in the liver.
    Mori Y; Moriishi K; Matsuura Y
    Int J Biochem Cell Biol; 2008; 40(8):1437-42. PubMed ID: 18321762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.
    Moriya K; Fujie H; Shintani Y; Yotsuyanagi H; Tsutsumi T; Ishibashi K; Matsuura Y; Kimura S; Miyamura T; Koike K
    Nat Med; 1998 Sep; 4(9):1065-7. PubMed ID: 9734402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct susceptibility of dendritic cell subsets to hepatitis C virus infection: a plausible mechanism of dendritic cell dysfunction.
    Kanto T; Hayashi N
    J Gastroenterol; 2004 Aug; 39(8):811-2. PubMed ID: 15338382
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sequential monitoring of various HCV-related markers in chronic hepatitis C with interferon treatment].
    Nagayama R; Shoji S; Miyake K
    Nihon Rinsho; 1994 Jul; 52(7):1789-93. PubMed ID: 7521419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C.
    Longman RS; Talal AH; Jacobson IM; Rice CM; Albert ML
    J Infect Dis; 2005 Aug; 192(3):497-503. PubMed ID: 15995965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Involvement of dendritic cell dysfunction in the persistence of hepatitis C virus infection].
    Kanto T; Hayashi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):170-4. PubMed ID: 15359787
    [No Abstract]   [Full Text] [Related]  

  • 30. Significance of alterations in PBMC immunophenotype of children with chronic viral hepatitis C-- the role of dendritic cells.
    Mozer-Lisewska I; Dworacki G; Kaczmarek E; Sluzewski W; Kaczmarek M; Woźniak A; Zeromski J
    Scand J Immunol; 2006 Apr; 63(4):311-9. PubMed ID: 16623932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Predictive value of diverse viral factors in the response to treatment with interferon in patients with chronic hepatitis C].
    Giménez-Barcons M; Tajahuerce A; Sáiz JC
    Gastroenterol Hepatol; 1998 Oct; 21(8):404-12. PubMed ID: 9844281
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.
    Krishnadas DK; Ahn JS; Han J; Kumar R; Agrawal B
    Int Immunol; 2010 Jun; 22(6):491-502. PubMed ID: 20410260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment.
    Rollier C; Drexhage JA; Verstrepen BE; Verschoor EJ; Bontrop RE; Koopman G; Heeney JL
    Hepatology; 2003 Oct; 38(4):851-8. PubMed ID: 14512872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interferon treatment of chronic hepatitis C viral hepatitis patients with normal transaminases].
    Remy AJ; Blanc P
    Gastroenterol Clin Biol; 1998; 22(8-9):748-9. PubMed ID: 9823572
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are FoxP3(+) cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C?
    Westin J; Hellstrand K; Dhillon AP; Lagging M;
    J Viral Hepat; 2011 Feb; 18(2):149-51. PubMed ID: 20196808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functionality of the immune system in patients with chronic hepatitis C: trial by superinfections and vaccinations.
    Isaguliants MG
    Expert Rev Vaccines; 2007 Aug; 6(4):527-37. PubMed ID: 17669007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
    Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
    Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
    Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.